| Stage | ALAB | % of rev | WFRD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $392M | 100.00% | $1.1B | 100.00% | WFRD ×2.91 |
| Gross profit | $288M | 73.28% | $374M | 32.72% | ALAB +40.6pp |
| Operating income | $89M | 22.74% | $153M | 13.39% | ALAB +9.4pp |
| Pre-tax income | $103M | 26.20% | $129M | 11.29% | ALAB +14.9pp |
| Net income | $153M | 39.01% | $125M | 10.94% | ALAB +28.1pp |
| Stage | ALAB | WFRD | Gap · A − B |
|---|---|---|---|
| Revenue | $392M100.00% | $1.1B100.00% | WFRD ×2.91 |
| Gross profit | 73.28%$288M | 32.72%$374M | ALAB +40.6pp |
| Operating income | 22.74%$89M | 13.39%$153M | ALAB +9.4pp |
| Pre-tax income | 26.20%$103M | 11.29%$129M | ALAB +14.9pp |
| Net income |
| 39.01%$153M |
| 10.94%$125M |
| ALAB +28.1pp |